
Humana (HUM) Stock Forecast & Price Target
Humana (HUM) Analyst Ratings
Bulls say
Humana's positive outlook is supported by an increase in the 2025 earnings per share (EPS) estimate to $17.06, reflecting strong second-quarter results and revised guidance. The company's anticipated year-over-year earnings growth for 2027 is driven by the implementation of margin initiatives, despite estimated stability in Star ratings and the absence of recovered bonus payments. Additionally, Humana's commitment to environmental sustainability is noteworthy, as the company has surpassed its goals with a reduction of over 20% in greenhouse gas emissions since 2017, highlighting its operational efficiency and long-term strategic planning.
Bears say
Humana's management anticipates a slight decline in earnings per share (EPS) for 2026 compared to 2025, primarily due to ongoing challenges related to the Stars program, despite efforts to enhance margins. Furthermore, a downside scenario suggests that EPS for fiscal year 2027 could be approximately 10% lower than estimates, attributable to increased investments aimed at supporting recovery in the Stars program. The company's reliance on government-sponsored programs and the potential for a benefit gap amid competitive pressures also contribute to a cautious outlook on its financial stability moving forward.
This aggregate rating is based on analysts' research of Humana and is not a guaranteed prediction by Public.com or investment advice.
Humana (HUM) Analyst Forecast & Price Prediction
Start investing in Humana (HUM)
Order type
Buy in
Order amount
Est. shares
0 shares